| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Chief Patient &Ext Af Off | EVP, Chief Patient Officer | EVP, CRO
1 company
Sachdev Amit is an EVP Chief Patient &Ext Af Off at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $31.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP Chief Patient &Ext Af Off | Sell | 32 | $430.93 | $13,789.76 | - | +6.9% | -0.7% | |
| Feb 26, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP Chief Patient &Ext Af Off | Sell | 3,004 | $425.70 | $1,278,802.80 | -5.2% | +3.1% | +10.8% | |
| Feb 21, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP Chief Patient &Ext Af Off | Sell | 3,191 | $421.77 | $1,345,868.07 | -5.0% | +5.3% | +14.5% | |
| Feb 20, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP Chief Patient &Ext Af Off | Sell | 4,254 | $420.79 | $1,790,040.66 | -6.2% | +6.0% | +12.2% | |
| Feb 12, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP Chief Patient &Ext Af Off | Sell | 3,222 | $420.24 | $1,354,013.28 | -4.2% | +2.7% | +8.8% | |
| Nov 15, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP Chief Patient &Ext Af Off | Sell | 35 | $369.92 | $12,947.20 | - | +19.1% | +38.5% | |
| Aug 10, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sell | 10,031 | $350.00 | $3,510,850.00 | -14.6% | +8.5% | +34.9% | |
| Nov 15, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sell | 51 | $187.19 | $9,546.78 | - | +23.7% | +63.4% | |
| May 17, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sell | 45 | $216.35 | $9,735.87 | - | -11.7% | +21.0% | |
| Apr 27, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 3,884 | $216.06 | $839,193.14 | -3.1% | -7.7% | +24.0% |